Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Nylon Membrane Filter Produces Highly Effective Reduction of Endotoxins

Published: Thursday, October 03, 2013
Last Updated: Thursday, October 03, 2013
Bookmark and Share
Hydrofil HTZ from Porvair Filtration Group.

Porvair Filtration Group has introduced Hydrofil HTZ - an innovative dual 0.2µm membrane sterilization filter cartridge that incorporates a pharmaceutical grade, positively charged Nylon 6,6 membrane.

The positive zeta-potential of the nylon membrane enables highly effective reduction of most endotoxins derived from bacteria which typically have a negative charge in water. The dual membrane structure results in a significant increase in the endotoxin adsorption capacity of the filter.

Applications for Hydrofil HTZ include GMP pharmaceutical grade water systems where endotoxins levels need to be kept below Limulus Amebocyte Lysate (LAL) assay detection limits and recirculation of parenteral products through endotoxin removal filters to allow batch release.

Hydrofil HTZ filters are highly resistant to integrity failure caused by steam sterilization or autoclave cycles and have excellent chemical compatibility characteristics.

Porvair’s sterilizing grade cartridges are integrity tested, with each individual module’s value recorded to ensure product safety.

The materials of construction are approved by the Federal Drug Administration (FDA) and meet the standards of the United States Pharmacopeia Class VI (USP VI).

Porvair Filtration Group has over 25 years experience in providing innovative solutions that meet the customer’s requirements as well as standards set by regulatory authorities.

Manufacturing of Porvair’s high performance, cost effective products is underpinned by a quality assurance programme, cGMP practices and clean room environment to ensure products meet the stringent requirements of the Pharmaceutical, Generics and Veterinary Medicines industry.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Porvair Expands Its Operations at New Milton
Expansion to provide manufacturing capacity to support future growth of the business.
Thursday, February 13, 2014
Contract Design, Manufacture and Assembly of Regulatory Compliant Polymer Products
Porvair Filtration Group has opened a new Class 100000 clean room facility at its Wrexham, UK site.
Friday, March 12, 2010
Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!